15Q4WEB002_tpi_logo_main_02-01.png
TPI Composites, Inc. Announces First Quarter 2021 Earnings Results – Operational Execution Fuels Double-Digit Net Sales Growth
May 06, 2021 16:01 ET | TPI Composites, Inc.
SCOTTSDALE, Ariz., May 06, 2021 (GLOBE NEWSWIRE) -- TPI Composites, Inc. (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, today reported financial...
Nabriva logo.png
Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
May 06, 2021 16:01 ET | Nabriva Therapeutics US, Inc
-First quarter of full complement of 60 sales representatives further expanding the reach of XENLETA® (lefamulin) and SIVEXTRO® (tedizolid phosphate) in the community- -Commenced exclusive...
FGI logo.jpg
Franchise Group, Inc. Announces Fiscal 2021 First Quarter Financial Results
May 06, 2021 16:01 ET | Franchise Group, Inc.
INCREASES ANNUAL GUIDANCE ORLANDO, Fla., May 06, 2021 (GLOBE NEWSWIRE) -- Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced the financial results of its...
BrainsWay 2021 logo.jpg
BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021
May 06, 2021 16:01 ET | BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, May 06, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment...
Oncternal.png
Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results
May 06, 2021 16:01 ET | Oncternal Therapeutics
Interim results of a Phase 1b trial of cirmtuzumab and paclitaxel in locally advanced/unresectable or metastatic HER2-negative breast cancer compare favorably to historical single-agent paclitaxel...
Logo.JPG
Research Frontiers Reports First Quarter 2021 Financial Results
May 06, 2021 16:01 ET | Research Frontiers Incorporated
Management to Host Conference Call at 4:30 p.m. WOODBURY, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter...
iTEOS.jpg
iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021
May 06, 2021 16:01 ET | iTeos Therapeutics Inc.
CAMBRIDGE, Mass. and GOSSELIES, Belgium, May 06, 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development...
Collegium_rgb_large_R.jpg
Collegium Reports Record Quarterly Revenue of $87.7 Million
May 06, 2021 16:01 ET | Collegium Pharmaceutical, Inc.
– Net Income of $15.7 Million and Adjusted EBITDA of $45.3 Million in the First Quarter of 2021 – – Nucynta® Franchise and Adjusted EBITDA 2021 Guidance Range Raised – – Colleen Tupper Appointed...
corcept.png
Addition of Relacorilant to Nab-Paclitaxel Improves Progression Free Survival (PFS) in Controlled, Phase 2 trial of 178 Patients with Platinum Resistant Ovarian Cancer
May 06, 2021 16:01 ET | Corcept Therapeutics Incorporated
Women with platinum resistant ovarian cancer experienced longer progression free survival with relacorilant plus nab-paclitaxel than with nab-paclitaxel aloneWomen who received a higher dose of...
Farmer Brothers Company Logo
Farmer Bros. Co. Reports Third Quarter Fiscal 2021 Financial Results
May 06, 2021 16:00 ET | Farmer Bros. Co.
NORTHLAKE, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ: FARM) (the "Company") today reported financial results for its third fiscal quarter ended March 31, 2021. Third Quarter...